Understanding Multidrug Resistance in Colon Cancer Cells
Author Information
Author(s): G. Toffoli, A. Viell, L. Tumiotto, G. Biscontin, C. Rossi, M. Boiocchi
Primary Institution: Centro di Riferimento Oncologico, Aviano, Italy
Hypothesis
The multidrug-resistant phenotype in human colon carcinoma cell lines is a multifactorial phenomenon.
Conclusion
The study found that multidrug resistance in colon cancer cells is due to various biochemical mechanisms that differ among cell lines.
Supporting Evidence
- All drug-resistant sublines exhibited the MDR phenotype.
- mdrl mRNA expression levels increased in all drug-resistant sublines.
- Intracellular drug resistance increased uniformly across all MDR sublines.
Takeaway
Some cancer cells can resist multiple drugs, and this happens for different reasons in different types of cells.
Methodology
The study involved deriving drug-resistant sublines from human colon carcinoma cell lines and analyzing their resistance patterns and drug accumulation.
Limitations
The study does not identify all the biochemical mechanisms contributing to multidrug resistance.
Participant Demographics
Human colon carcinoma cell lines (LoVo, DLD1, SW948).
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website